Trademark: 90766689
Status Date
Tuesday, May 30, 2023
Registration Number
7064864
Registration Date
Tuesday, May 30, 2023
Filing Date
Thursday, June 10, 2021
Published for Opposition
Tuesday, March 14, 2023
5 Cells and biological preparations intended for medical and clinical use, namely, blood, stem cells, placental-derived cells, umbilical cord cells, placental-derived T cells, chimeric antigen receptor (CAR) T cells, umbilical cord blood, and placental allograft tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; human amniotic membrane and human chorionic membrane intended for subsequent implantation; human collagen compositions and extracellular matrix compositions intended for subsequent implantation; biological products for medical use, namely, placental-derived natural killer cells, and placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen; biological tissue intended for use as a wound covering and burn dressing; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds and burns; and written instructional materials distributed in connection with the aforesaid goods; biological products for medical use, namely, placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen
1 bioengineered cells for use in scientific, laboratory and medical research; human allograft tissue made from human umbilical cords and human placentas for use in scientific, laboratory and medical research; placental-derived cells, chimeric antigen receptor (CAR) T cells, and placental-derived T cells with a chimeric antigen receptor (CAR), all for use in scientific, laboratory and medical research
CY CART NINETEEN; CY CART ONE NINE
May 30, 2023
Notice Of Registration Confirmation Emailed
May 30, 2023
Registered-Principal Register
Mar 14, 2023
Official Gazette Publication Confirmation E-Mailed
Mar 14, 2023
Published For Opposition
Feb 22, 2023
Notification Of Notice Of Publication E-Mailed
Feb 6, 2023
Approved For Pub - Principal Register
Feb 3, 2023
Examiner's Amendment Entered
Feb 3, 2023
Notification Of Examiners Amendment E-Mailed
Feb 3, 2023
Examiners Amendment E-Mailed
Feb 3, 2023
Examiners Amendment -Written
Dec 16, 2022
Teas Request For Reconsideration Received
Dec 16, 2022
Ex Parte Appeal-Instituted
Dec 16, 2022
Jurisdiction Restored To Examining Attorney
Dec 16, 2022
Exparte Appeal Received At Ttab
Jun 16, 2022
Notification Of Final Refusal Emailed
Jun 16, 2022
Final Refusal E-Mailed
Jun 16, 2022
Final Refusal Written
Apr 13, 2022
Teas/Email Correspondence Entered
Apr 12, 2022
Correspondence Received In Law Office
Apr 12, 2022
Teas Response To Office Action Received
Mar 9, 2022
Notice Of Acceptance Of Amendment To Allege Use E-Mailed
Mar 8, 2022
Use Amendment Accepted
Mar 8, 2022
Notification Of Non-Final Action E-Mailed
Mar 8, 2022
Non-Final Action E-Mailed
Mar 8, 2022
Non-Final Action Written
Mar 1, 2022
Assigned To Examiner
Sep 2, 2021
Amendment To Use Processing Complete
Sep 2, 2021
Use Amendment Filed
Jun 15, 2021
Teas Amendment Of Use Received
Aug 31, 2021
New Application Office Supplied Data Entered
Jun 14, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
